Sasken

Q3 Earnings picks: Commodity, food processing and IT stocks resonate

GNFC reported excellent traction in its earnings (PAT: 241% YoY) aided by 40 percent topline growth, EBITDA margin expansion (+906 bps) and lower interest expense. This was mainly led by Chemicals division

Sebi bans Amadhi Investments for 10 years in IPO case

The Securities and Exchange Board of India (Sebi) found that Amadhi Investments financed Sugandh Estates and Investments in the IPOs of IDFC, Sasken and FCS Software Solutions with the purpose of cornering shares reserved for retail investors.

Here's how small cap stocks opened on December 13

Small cap stocks rally as Bernanke sticks to stimulus

Here's how small cap stocks opened on September 19

Buzzing small cap stocks on September 18

Here's how small cap stocks opened on September 18

Stocks in news: Mangalore Chem, Deepak Fert, Tech Mahindra

Stay away from Ajanta Pharma, Sasken: SP Tulsian

SP Tulsian, sptulsian.com advises traders to stay away from Ajanta Pharma and Sasken.

Likely to see strong growth in H2FY13: Sasken Communication

After improved EBITDA margins in company's services and products business, Neeta Revankar, CFO, Sasken has a positive outlook for H2 FY13. In an interview with CNBC-TV18 she said that the company is headed for growth and is also set for an open market buyback in the second or third week of May.